PTCT
PTC Therapeutics Inc
Price:  
35.10 
USD
Volume:  
287,550.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

PTCT EV/EBITDA

-169.1%
Upside

As of 2024-10-06, the EV/EBITDA ratio of PTC Therapeutics Inc (PTCT) is -541.29. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. PTCT's latest enterprise value is 4,432.66 mil USD. PTCT's TTM EBITDA according to its financial statements is -8.19 mil USD. Dividing these 2 quantities gives us the above PTCT EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.6x - 16.9x 14.9x
Forward P/E multiples 16.8x - 19.1x 17.6x
Fair Price (24.31) - (24.32) (24.26)
Upside -169.3% - -169.3% -169.1%
35.10 USD
Stock Price
(24.26) USD
Fair Price

PTCT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-10-04 -541.30
2024-10-03 -543.83
2024-10-02 -553.79
2024-10-01 -550.22
2024-09-30 -560.08
2024-09-27 -564.40
2024-09-26 -565.34
2024-09-25 -555.76
2024-09-24 -554.63
2024-09-23 -556.79
2024-09-20 -555.76
2024-09-19 -551.25
2024-09-18 -544.86
2024-09-17 -541.01
2024-09-16 -528.80
2024-09-13 -530.87
2024-09-12 -518.75
2024-09-11 -514.71
2024-09-10 -507.86
2024-09-09 -506.73
2024-09-06 -507.86
2024-09-05 -508.42
2024-09-04 -527.11
2024-09-03 -525.42
2024-08-30 -543.36
2024-08-29 -545.33
2024-08-28 -542.14
2024-08-27 -543.36
2024-08-26 -539.51
2024-08-23 -532.37
2024-08-22 -525.61
2024-08-21 -530.31
2024-08-20 -534.63
2024-08-19 -535.28
2024-08-16 -525.51
2024-08-15 -521.95
2024-08-14 -510.02
2024-08-13 -510.96
2024-08-12 -505.70
2024-08-09 -505.51
2024-08-08 -516.40
2024-08-07 -510.77
2024-08-06 -513.02
2024-08-05 -502.78
2024-08-02 -513.96
2024-08-01 -518.66
2024-07-31 -529.55
2024-07-30 -521.85
2024-07-29 -517.06
2024-07-26 -531.81